Chiloiro Sabrina, Costanza Flavia, Riccardi Elena, Giampietro Antonella, De Marinis Laura, Bianchi Antonio, Pontecorvi Alfredo, Giustina Andrea
Dipartimento di Medicina e Chirurgia traslazionale, Università Cattolica del Sacro Cuore, Largo A. Gemelli, number 8, Rome, Italy.
Pituitary Unit, Department of Endocrinology and Diabetes, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Pituitary. 2024 Dec;27(6):847-859. doi: 10.1007/s11102-024-01439-3. Epub 2024 Aug 24.
The evidence that pituitary hormones may bypass peripheral endocrine glands to exert remarkable effects on the skeleton is gaining ground. Both hormonal excess and deficit may determine impairment in bone structure, and they commonly result in bone loss in patients affected by pituitary and neuroendocrine disorders. Vertebral fractures are the most common skeletal alterations and may occur independently of bone mass. Use of vitamin D (VD) supplementation is still debated in this setting. This review will focus on the interactions between different metabolites of VD and pituitary hormones, and the effects of VD supplementation on bone metabolism in patients with pituitary diseases.
垂体激素可能绕过外周内分泌腺对骨骼产生显著影响,这一证据越来越站得住脚。激素过多和不足都可能导致骨结构受损,并且它们通常会导致垂体和神经内分泌疾病患者出现骨质流失。椎体骨折是最常见的骨骼改变,可能独立于骨量而发生。在这种情况下,维生素D(VD)补充剂的使用仍存在争议。本综述将重点关注VD不同代谢产物与垂体激素之间的相互作用,以及VD补充剂对垂体疾病患者骨代谢的影响。